查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2026811

心血管醫療設備市場預測至2034年－按器材類型、應用、最終用戶和地區分類的全球分析

Cardiovascular Devices Market Forecasts to 2034 - Global Analysis By Device Type, Application (Coronary Artery Disease, Heart Failure, Cardiac Arrhythmia and Other Applications), End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的數據，預計到 2026 年，全球心血管醫療設備市場規模將達到 870 億美元，並在預測期內以 9.9% 的複合年成長率成長，到 2034 年將達到 1853 億美元。

心血管醫療設備是用於診斷、治療和監測疾病及循環系統的醫療設備。這些設備在醫學領域發揮著至關重要的作用，用於治療各種心血管疾病，包括心律不整、冠狀動脈疾病和心臟衰竭。代表性設備包括心律調節器、去心房顫動、影像設備、監測系統和導管。它們的重要性在於能夠提供有效的治療方案、實現精準診斷並改善患者預後，所有這些都顯著提升了心臟健康水平並挽救了許多生命。

世界衛生組織（世衛組織）表示，約 75% 的心血管疾病相關死亡發生在低收入和中等收入國家。

心血管疾病盛行率增加

心血管疾病（CVD）的日益流行，例如心臟衰竭、心律不整和冠狀動脈疾病（CAD），歸因於多種因素，包括久坐的生活方式、不健康的飲食、吸煙和人口老化。日益加重的疾病負擔推動了對創新心血管醫療設備和技術的需求。植入式心臟整流去顫器（ICD）、心臟心律調節器、藥物釋放型支架和心臟監測設備等醫療設備在各種心血管疾病的診斷、治療和管理中發揮著至關重要的作用。這些先進技術有助於改善患者預後、降低死亡率並全面提高患者的生活品質（QOL）。因此，市場擴張的需求日益成長。

研發活動面臨的障礙日益增多

監管力度加大、安全標準日益嚴格以及大規模臨床試驗的需求，顯著增加了研發成本和研發週期。這些障礙對中小企業和新創企業的影響尤其顯著，限制了它們進入市場和創新的能力。成熟的大型企業也面臨許多挑戰，例如需要對研發進行大量投資。這些日益增多的研發障礙阻礙了新型心血管醫療設備的及時上市，並抑制了創新和市場成長。

遠端醫療和遠距監測

遠端醫療和遠端監測能夠即時遠端監測生命徵象、心率和其他相關數據，從而促進患者照護。對於心血管疾病患者而言，居家監測的便利性減少了就醫次數，並提高了醫療服務的可近性。先進的穿戴式設備、行動應用程式和互聯平台使醫療專業人員能夠遠端評估患者病情，及時干預，提供個人化護理，並最終改善患者的治療效果。遠端醫療和遠距監測在循環系統領域的整合也為創新鋪平了道路，促進了更精密、更便利、更有效的、專為遠端監測和遠端醫療應用而設計的循環系統的研發。

嚴格的規定

監管要求的演變和日益嚴格可能導致核准流程延長、合規成本增加，以及新醫療設備上市門檻升高。這些法規可能會抑制創新和市場准入，尤其對於資源有限、難以應對複雜監管環境的中小型企業而言。此外，監管變化和不確定性也會擾亂現有的市場策略和投資，影響產品開發進度和市場競爭力。

新冠疫情的影響

新冠疫情對心血管醫療設備市場產生了多方面重大影響。初期，應對疫情是首要任務，導致醫療資源重新分配，擇期手術和心血管疾病診斷減少，因為患者不願意尋求非緊急醫療服務。供應鏈中斷和生產限制也影響了醫療設備的供應。然而，疫情加速了遠端醫療和遠距監測解決方案的普及，推動了心血管護理領域數位醫療的創新。隨著疫苗接種率的提高和醫療系統對「新常態」的適應，擇期手術逐漸恢復。

在預測期內，診斷和監測設備領域預計將佔據最大的市場佔有率。

診斷和監測設備領域預計將佔據最大的市場佔有率，這主要得益於旨在檢測、監測和評估心血管疾病的先進技術。這些設備能夠即時監測心率、血壓和其他生命徵象，有助於早期發現異常情況並促進患者照護。此外，這些設備在各種心血管疾病的診斷中發揮著至關重要的作用，為醫療專業人員提供準確評估、制定個人化治療策略和改善患者預後所需的重要數據，最終有助於改善心臟疾病的管理和護理。

預計在預測期內，冠狀動脈疾病（CAD）細分市場將呈現最高的複合年成長率。

預計在預測期內，冠狀動脈疾病（CAD）領域將顯著成長。冠狀動脈疾病（CAD）是指為心臟輸送富氧血液的冠狀動脈發生狹窄或阻塞。這些裝置有助於恢復心臟血流，緩解症狀，並降低心肌梗塞的風險。專門用於CAD的醫療設備可支援經皮冠狀動脈介入治療（PCI）和冠狀動脈繞道手術手術（CABG）等治療，在治療這種常見的心血管疾病中發揮至關重要的作用，並有助於改善患者的心臟健康和生活品質。

市佔率最大的地區：

在預測期內，亞太地區佔據了最大的市場佔有率。該地區涵蓋了中國、印度和日本等國家用於治療心血管疾病的各種醫療技術。這個快速成長的市場在心臟節律管理設備、支架和診斷工具等領域取得了顯著進展。此外，心血管疾病發病率的上升、醫療基礎設施的完善以及創新醫療解決方案的普及等因素也推動了市場擴張。技術創新和不斷提高的健康意識共同推動了亞太地區對心血管醫療設備需求的激增。

複合年成長率最高的地區：

預計北美地區在整個預測期內將保持盈利成長，主要成長動力來自美國和加拿大，並得益於其穩健成熟的市場環境。北美市場以其先進的醫療技術而聞名，涵蓋了包括心臟心律調節器、去心房顫動、支架和影像設備在內的各種心血管醫療設備。此外，高昂的醫療費用支出、先進的醫療基礎設施和龐大的患者群體也推動了市場成長。微創手術的創新，以及對研發的高度重視，使該地區成為尖端心血管技術的主導，並創造了以改善患者預後為核心的競爭環境。

免費客製化服務：

所有購買此報告的客戶均可享受以下免費自訂選項之一：

  • 企業概況
    • 對其他市場公司（最多 3 家公司）進行全面分析
    • 對主要公司進行SWOT分析（最多3家公司）
  • 區域細分
    • 應客戶要求，我們提供主要國家和地區的市場估算和預測，以及複合年成長率（註：需進行可行性檢查）。
  • 競爭性標竿分析
    • 根據產品系列、地理覆蓋範圍和策略聯盟對重點公司進行基準分析。

目錄

第1章執行摘要

第2章：引言

  • 概括
  • 相關利益者
  • 調查範圍
  • 調查方法
  • 研究材料

第3章 市場趨勢分析

  • 促進因素
  • 抑制因子
  • 機會
  • 威脅
  • 應用分析
  • 最終用戶分析
  • 新興市場
  • 新冠疫情的感染疾病

第4章：波特五力分析

  • 供應商的議價能力
  • 買方的議價能力
  • 替代品的威脅
  • 新進入者的威脅
  • 競爭公司之間的競爭

第5章 全球心血管醫療設備市場：依器材類型分類

  • 診斷和監測設備
    • 遠端心電圖監測
    • 心電圖（ECG）
  • 治療及外科器械
    • 心臟輔助裝置
    • 導管
    • 心臟節律管理裝置
    • 接枝
    • 支架
    • 心臟瓣膜
  • 其他設備類型

第6章 全球心血管醫療設備市場：依應用領域分類

  • 冠狀動脈疾病（CAD）
  • 心臟衰竭
  • 心律不整
  • 其他用途

第7章 全球心血管醫療設備市場：依最終用戶分類

  • 專科診所
  • 醫院
  • 心臟中心
  • 門診手術中心

第8章 全球心血管醫療設備市場：按地區分類

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 其他歐洲國家
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 其他亞太國家
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 其他南美國家
  • 中東和非洲
    • 沙烏地阿拉伯
    • UAE
    • 卡達
    • 南非
    • 其他中東和非洲國家

第9章 主要發展

  • 合約、夥伴關係、合作關係、合資企業
  • 收購與併購
  • 新產品發布
  • 業務拓展
  • 其他關鍵策略

第10章：公司簡介

  • Abbott
  • Cardinal Health
  • Boston Scientific Corporation
  • General Electric（GE Healthcare）
  • Medtronic
  • WL Gore & Associates, Inc.
  • Biotronik
  • Canon Medical Systems Corporation
  • Siemens Healthcare Gmbh
  • Edwards Lifesciences Corporation
  • Livanova PLC
  • B. Braun Melsungen AG
  • Johnson & Johnson Services, Inc.
  • Terumo Cardiovascular Systems Corporation
  • Philips Healthcare
  • Microport Scientific Corporation
  • Lepu Medical Technology（Beijing）Co Ltd
  • Occlutech
  • Getinge AB
  • Atricure, Inc
Product Code: SMRC24573

According to Stratistics MRC, the Global Cardiovascular Devices Market is accounted for $87.0 billion in 2026 and is expected to reach $185.3 billion by 2034 growing at a CAGR of 9.9% during the forecast period. Cardiology devices are medical equipment intended to diagnose, treat, and monitor diseases and cardiovascular systems. They play a vital role in healthcare by treating a range of cardiovascular disorders, including arrhythmias, coronary artery disease, and heart failure. Some of these devices are pacemakers, defibrillators, imaging equipment, monitoring systems, and catheters. Their importance derives from their capacity to provide effective treatment initiatives, facilitate precise diagnosis, and improve patient outcomes-all of which significantly raise standards for cardiac health and save lives.

According to the World Health Organization, around 75% of the cardiovascular diseases related deaths occur in low and middle income countries.

Market Dynamics:

Driver:

Rising prevalence of cardiovascular diseases

The rising prevalence of cardiovascular diseases (CVDs) such heart failure, arrhythmias, and coronary artery disease (CADD) is attributed to several factors, including sedentary lifestyles, unhealthy diets, tobacco use, and ageing populations. This escalating disease burden necessitates a greater demand for innovative cardiovascular devices and technologies. Devices such as implantable cardioverter-defibrillators (ICDs), pacemakers, drug-eluting stents, and cardiac monitoring devices play pivotal roles in diagnosing, treating, and managing various cardiovascular conditions. These advanced technologies aid in improving patient outcomes, reducing mortality rates, and enhancing the overall quality of life for affected individuals. Therefore, there is an increasing demand for market expansion.

Restraint:

Increasing barriers in R&D activities

Heightened regulatory scrutiny, demanding safety standards, and the necessity for extensive clinical trials significantly elevate R&D costs and timelines. These barriers disproportionately affect smaller companies and start-ups, limiting their ability to enter the market and innovate. Established players also encounter impediments, requiring substantial investments in R&D. These mounting hurdles in R&D hinder the timely introduction of novel cardiovascular devices, impeding innovation and market growth.

Opportunity:

Telemedicine and remote monitoring

Telemedicine and remote monitoring facilitate continuous patient care by enabling remote monitoring of vital signs, cardiac rhythms, and other relevant data in real-time. For cardiovascular patients, this offers the convenience of home-based monitoring, reducing hospital visits, and enhancing accessibility to healthcare. Advanced wearable devices, mobile apps, and connected platforms allow healthcare professionals to remotely assess patients' conditions, provide timely interventions, and offer personalised care, ultimately improving patient outcomes. The integration of telemedicine and remote monitoring in cardiovascular also opens avenues for innovation, driving the development of more sophisticated, user-friendly, and effective cardiovascular devices tailored for remote monitoring and telehealth applications.

Threat:

Stringent regulations

Evolving and stringent regulatory requirements can result in prolonged approval processes, increased compliance costs, and heightened barriers for new device introductions. These regulations may inhibit innovation and market entry, particularly for smaller companies with limited resources to navigate complex regulatory landscapes. Also, regulatory changes or uncertainties might disrupt existing market strategies and investments, impacting product development timelines and market competitiveness.

Covid-19 Impact

The COVID-19 pandemic significantly affected the cardiovascular device market in various ways. Initially, the focus shifted towards managing the pandemic, causing a decline in elective procedures and diagnostics for cardiovascular conditions due to healthcare resource reallocation and patient reluctance to seek non-emergency care. Supply chain disruptions and manufacturing constraints also impacted device availability. However, the pandemic accelerated the adoption of telemedicine and remote monitoring solutions, driving innovation in digital health for cardiovascular care. As vaccination rates increased and healthcare systems adapted to the new normal, there was a gradual rebound in elective procedures.

The Diagnostic and Monitoring Devices segment is expected to be the largest during the forecast period

The Diagnostic and Monitoring Devices segment is estimated to hold the largest share, due to the advanced technologies designed to detect, monitor, and assess cardiovascular conditions. They enable real-time monitoring of heart rhythms, blood pressure, and other vital signs, aiding in the early detection of abnormalities and facilitating continuous patient care. Additionally, these devices play a pivotal role in diagnosing various cardiovascular diseases, providing healthcare professionals with crucial data for accurate assessments, personalised treatment strategies, and improved patient outcomes, ultimately contributing to better management and care of cardiac

The Coronary Artery Disease (CAD) segment is expected to have the highest CAGR during the forecast period

The Coronary Artery Disease (CAD) segment is anticipated to have lucrative growth during the forecast period. Coronary artery disease (CAD) is a narrowing or blockage of your coronary arteries, which supply oxygen-rich blood to the heart. These devices help restore blood flow to the heart, alleviate symptoms, and reduce the risk of heart attacks. CAD-specific devices aid in interventions such as percutaneous coronary interventions (PCI) and coronary artery bypass grafting (CABG), playing a pivotal role in managing this prevalent cardiovascular condition and improving patients' cardiac health and quality of life.

Region with largest share:

Asia Pacific commanded the largest market share during the extrapolated period. It encompasses a diverse landscape of medical technologies focused on treating heart-related conditions across countries like China, India, Japan, and others. This rapidly growing market features advancements in cardiac rhythm management devices, stents, diagnostic tools, and more. Moreover, factors such as rising cardiovascular diseases, improving healthcare infrastructure, and increasing adoption of innovative medical solutions contribute to the market's expansion. With a blend of technological innovation and growing healthcare awareness, the Asia Pacific region is witnessing a surge in demand for cardiovascular devices.

Region with highest CAGR:

North America is expected to witness profitable growth over the projection period, owing to its robust and mature landscape, encompassing the United States and Canada as key contributors. Known for its advanced medical technologies, this market hosts a wide array of cardiovascular devices, including pacemakers, defibrillators, stents, and imaging tools. Furthermore, factors such as high healthcare spending, sophisticated healthcare infrastructure, and a large patient pool drive market growth. Innovations in minimally invasive procedures, coupled with a strong emphasis on research and development, contribute to the region's leadership in cutting-edge cardiovascular technologies, fostering a competitive market environment with a focus on improving patient outcomes

Key players in the market

Some of the key players in the Cardiovascular Devices Market include Abbott, Cardinal Health, Boston Scientific Corporation, General Electric (GE Healthcare), Medtronic, W. L. Gore & Associates, Inc., Biotronik, Canon Medical Systems Corporation, Siemens Healthcare GmbH., Edwards Lifesciences Corporation, LivaNova PLC, B. Braun Melsungen AG, Johnson & Johnson Services, Inc., Terumo Cardiovascular Systems Corporation, Philips Healthcare, MicroPort Scientific Corporation, Lepu Medical Technology(Beijing)Co Ltd, Occlutech, Getinge AB and AtriCure, Inc.

Key Developments:

In October 2022, Medtronic plc received United States FDA approval for expanded labeling of a cardiac lead that taps into the heart's natural electrical system, giving patients needed therapy while avoiding complications sometimes associated with traditional pacing methods, such as cardiomyopathy.

In October 2022, Biosense Webster, Inc., part of Johnson & Johnson MedTech launched the HELIOSTAR Balloon Ablation Catheter in Europe. The HELIOSTAR Balloon Ablation Catheter is indicated for use in the catheter-based cardiac electrophysiological mapping (stimulating and recording) of the atria and, when used with a compatible multi-channel RF generator, for cardiac ablation.

Device Types Covered:

  • Diagnostic and Monitoring Devices
  • Therapeutic and Surgical Devices
  • Other Device Types

Applications Covered:

  • Coronary Artery Disease (CAD)
  • Heart Failure
  • Cardiac Arrhythmia
  • Other Applications

End Users Covered:

  • Specialty Clinics
  • Hospitals
  • Cardiac Centers
  • Centers Ambulatory Surgical

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2023, 2024, 2025, 2026, 2027, 2028, 2030, 2032 and 2034
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Application Analysis
  • 3.7 End User Analysis
  • 3.8 Emerging Markets
  • 3.9 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Cardiovascular Devices Market, By Device Type

  • 5.1 Introduction
  • 5.2 Diagnostic and Monitoring Devices
    • 5.2.1 Remote Cardiac Monitoring
    • 5.2.2 Electrocardiogram (ECG)
  • 5.3 Therapeutic and Surgical Devices
    • 5.3.1 Cardiac Assist Devices
    • 5.3.2 Catheters
    • 5.3.3 Cardiac Rhythm Management Devices
    • 5.3.4 Grafts
    • 5.3.5 Stents
    • 5.3.6 Heart Valves
  • 5.4 Other Device Types

6 Global Cardiovascular Devices Market, By Application

  • 6.1 Introduction
  • 6.2 Coronary Artery Disease (CAD)
  • 6.3 Heart Failure
  • 6.4 Cardiac Arrhythmia
  • 6.5 Other Applications

7 Global Cardiovascular Devices Market, By End User

  • 7.1 Introduction
  • 7.2 Specialty Clinics
  • 7.3 Hospitals
  • 7.4 Cardiac Centers
  • 7.5 Centers Ambulatory Surgical

8 Global Cardiovascular Devices Market, By Geography

  • 8.1 Introduction
  • 8.2 North America
    • 8.2.1 US
    • 8.2.2 Canada
    • 8.2.3 Mexico
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 Italy
    • 8.3.4 France
    • 8.3.5 Spain
    • 8.3.6 Rest Of Europe
  • 8.4 Asia Pacific
    • 8.4.1 Japan
    • 8.4.2 China
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 New Zealand
    • 8.4.6 South Korea
    • 8.4.7 Rest Of Asia Pacific
  • 8.5 South America
    • 8.5.1 Argentina
    • 8.5.2 Brazil
    • 8.5.3 Chile
    • 8.5.4 Rest Of South America
  • 8.6 Middle East & Africa
    • 8.6.1 Saudi Arabia
    • 8.6.2 UAE
    • 8.6.3 Qatar
    • 8.6.4 South Africa
    • 8.6.5 Rest Of Middle East & Africa

9 Key Developments

  • 9.1 Agreements, Partnerships, Collaborations And Joint Ventures
  • 9.2 Acquisitions & Mergers
  • 9.3 New Product Launch
  • 9.4 Expansions
  • 9.5 Other Key Strategies

10 Company Profiling

  • 10.1 Abbott
  • 10.2 Cardinal Health
  • 10.3 Boston Scientific Corporation
  • 10.4 General Electric (GE Healthcare)
  • 10.5 Medtronic
  • 10.6 W. L. Gore & Associates, Inc.
  • 10.7 Biotronik
  • 10.8 Canon Medical Systems Corporation
  • 10.9 Siemens Healthcare Gmbh
  • 10.10 Edwards Lifesciences Corporation
  • 10.11 Livanova PLC
  • 10.12 B. Braun Melsungen AG
  • 10.13 Johnson & Johnson Services, Inc.
  • 10.14 Terumo Cardiovascular Systems Corporation
  • 10.15 Philips Healthcare
  • 10.16 Microport Scientific Corporation
  • 10.17 Lepu Medical Technology(Beijing)Co Ltd
  • 10.18 Occlutech
  • 10.19 Getinge AB
  • 10.20 Atricure, Inc

List Of Tables

  • Table 1 Global Cardiovascular Devices Market Outlook, By Region (2023-2034) ($MN)
  • Table 2 Global Cardiovascular Devices Market Outlook, By Device Type (2023-2034) ($MN)
  • Table 3 Global Cardiovascular Devices Market Outlook, By Diagnostic And Monitoring Devices (2023-2034) ($MN)
  • Table 4 Global Cardiovascular Devices Market Outlook, By Remote Cardiac Monitoring (2023-2034) ($MN)
  • Table 5 Global Cardiovascular Devices Market Outlook, By Electrocardiogram (ECG) (2023-2034) ($MN)
  • Table 6 Global Cardiovascular Devices Market Outlook, By Therapeutic And Surgical Devices (2023-2034) ($MN)
  • Table 7 Global Cardiovascular Devices Market Outlook, By Cardiac Assist Devices (2023-2034) ($MN)
  • Table 8 Global Cardiovascular Devices Market Outlook, By Catheters (2023-2034) ($MN)
  • Table 9 Global Cardiovascular Devices Market Outlook, By Cardiac Rhythm Management Devices (2023-2034) ($MN)
  • Table 10 Global Cardiovascular Devices Market Outlook, By Grafts (2023-2034) ($MN)
  • Table 11 Global Cardiovascular Devices Market Outlook, By Stents (2023-2034) ($MN)
  • Table 12 Global Cardiovascular Devices Market Outlook, By Heart Valves (2023-2034) ($MN)
  • Table 13 Global Cardiovascular Devices Market Outlook, By Application (2023-2034) ($MN)
  • Table 14 Global Cardiovascular Devices Market Outlook, By Coronary Artery Disease (CAD) (2023-2034) ($MN)
  • Table 15 Global Cardiovascular Devices Market Outlook, By Heart Failure (2023-2034) ($MN)
  • Table 16 Global Cardiovascular Devices Market Outlook, By Cardiac Arrhythmia (2023-2034) ($MN)
  • Table 17 Global Cardiovascular Devices Market Outlook, By Other Applications (2023-2034) ($MN)
  • Table 18 Global Cardiovascular Devices Market Outlook, By End User (2023-2034) ($MN)
  • Table 19 Global Cardiovascular Devices Market Outlook, By Specialty Clinics (2023-2034) ($MN)
  • Table 20 Global Cardiovascular Devices Market Outlook, By Hospitals (2023-2034) ($MN)
  • Table 21 Global Cardiovascular Devices Market Outlook, By Cardiac Centers (2023-2034) ($MN)
  • Table 22 Global Cardiovascular Devices Market Outlook, By Centers Ambulatory Surgical (2023-2034) ($MN)
  • Table 23 North America Cardiovascular Devices Market Outlook, By Country (2023-2034) ($MN)
  • Table 24 North America Cardiovascular Devices Market Outlook, By Device Type (2023-2034) ($MN)
  • Table 25 North America Cardiovascular Devices Market Outlook, By Diagnostic And Monitoring Devices (2023-2034) ($MN)
  • Table 26 North America Cardiovascular Devices Market Outlook, By Remote Cardiac Monitoring (2023-2034) ($MN)
  • Table 27 North America Cardiovascular Devices Market Outlook, By Electrocardiogram (ECG) (2023-2034) ($MN)
  • Table 28 North America Cardiovascular Devices Market Outlook, By Therapeutic And Surgical Devices (2023-2034) ($MN)
  • Table 29 North America Cardiovascular Devices Market Outlook, By Cardiac Assist Devices (2023-2034) ($MN)
  • Table 30 North America Cardiovascular Devices Market Outlook, By Catheters (2023-2034) ($MN)
  • Table 31 North America Cardiovascular Devices Market Outlook, By Cardiac Rhythm Management Devices (2023-2034) ($MN)
  • Table 32 North America Cardiovascular Devices Market Outlook, By Grafts (2023-2034) ($MN)
  • Table 33 North America Cardiovascular Devices Market Outlook, By Stents (2023-2034) ($MN)
  • Table 34 North America Cardiovascular Devices Market Outlook, By Heart Valves (2023-2034) ($MN)
  • Table 35 North America Cardiovascular Devices Market Outlook, By Application (2023-2034) ($MN)
  • Table 36 North America Cardiovascular Devices Market Outlook, By Coronary Artery Disease (CAD) (2023-2034) ($MN)
  • Table 37 North America Cardiovascular Devices Market Outlook, By Heart Failure (2023-2034) ($MN)
  • Table 38 North America Cardiovascular Devices Market Outlook, By Cardiac Arrhythmia (2023-2034) ($MN)
  • Table 39 North America Cardiovascular Devices Market Outlook, By Other Applications (2023-2034) ($MN)
  • Table 40 North America Cardiovascular Devices Market Outlook, By End User (2023-2034) ($MN)
  • Table 41 North America Cardiovascular Devices Market Outlook, By Specialty Clinics (2023-2034) ($MN)
  • Table 42 North America Cardiovascular Devices Market Outlook, By Hospitals (2023-2034) ($MN)
  • Table 43 North America Cardiovascular Devices Market Outlook, By Cardiac Centers (2023-2034) ($MN)
  • Table 44 North America Cardiovascular Devices Market Outlook, By Centers Ambulatory Surgical (2023-2034) ($MN)
  • Table 45 Europe Cardiovascular Devices Market Outlook, By Country (2023-2034) ($MN)
  • Table 46 Europe Cardiovascular Devices Market Outlook, By Device Type (2023-2034) ($MN)
  • Table 47 Europe Cardiovascular Devices Market Outlook, By Diagnostic And Monitoring Devices (2023-2034) ($MN)
  • Table 48 Europe Cardiovascular Devices Market Outlook, By Remote Cardiac Monitoring (2023-2034) ($MN)
  • Table 49 Europe Cardiovascular Devices Market Outlook, By Electrocardiogram (ECG) (2023-2034) ($MN)
  • Table 50 Europe Cardiovascular Devices Market Outlook, By Therapeutic And Surgical Devices (2023-2034) ($MN)
  • Table 51 Europe Cardiovascular Devices Market Outlook, By Cardiac Assist Devices (2023-2034) ($MN)
  • Table 52 Europe Cardiovascular Devices Market Outlook, By Catheters (2023-2034) ($MN)
  • Table 53 Europe Cardiovascular Devices Market Outlook, By Cardiac Rhythm Management Devices (2023-2034) ($MN)
  • Table 54 Europe Cardiovascular Devices Market Outlook, By Grafts (2023-2034) ($MN)
  • Table 55 Europe Cardiovascular Devices Market Outlook, By Stents (2023-2034) ($MN)
  • Table 56 Europe Cardiovascular Devices Market Outlook, By Heart Valves (2023-2034) ($MN)
  • Table 57 Europe Cardiovascular Devices Market Outlook, By Application (2023-2034) ($MN)
  • Table 58 Europe Cardiovascular Devices Market Outlook, By Coronary Artery Disease (CAD) (2023-2034) ($MN)
  • Table 59 Europe Cardiovascular Devices Market Outlook, By Heart Failure (2023-2034) ($MN)
  • Table 60 Europe Cardiovascular Devices Market Outlook, By Cardiac Arrhythmia (2023-2034) ($MN)
  • Table 61 Europe Cardiovascular Devices Market Outlook, By Other Applications (2023-2034) ($MN)
  • Table 62 Europe Cardiovascular Devices Market Outlook, By End User (2023-2034) ($MN)
  • Table 63 Europe Cardiovascular Devices Market Outlook, By Specialty Clinics (2023-2034) ($MN)
  • Table 64 Europe Cardiovascular Devices Market Outlook, By Hospitals (2023-2034) ($MN)
  • Table 65 Europe Cardiovascular Devices Market Outlook, By Cardiac Centers (2023-2034) ($MN)
  • Table 66 Europe Cardiovascular Devices Market Outlook, By Centers Ambulatory Surgical (2023-2034) ($MN)
  • Table 67 Asia Pacific Cardiovascular Devices Market Outlook, By Country (2023-2034) ($MN)
  • Table 68 Asia Pacific Cardiovascular Devices Market Outlook, By Device Type (2023-2034) ($MN)
  • Table 69 Asia Pacific Cardiovascular Devices Market Outlook, By Diagnostic And Monitoring Devices (2023-2034) ($MN)
  • Table 70 Asia Pacific Cardiovascular Devices Market Outlook, By Remote Cardiac Monitoring (2023-2034) ($MN)
  • Table 71 Asia Pacific Cardiovascular Devices Market Outlook, By Electrocardiogram (ECG) (2023-2034) ($MN)
  • Table 72 Asia Pacific Cardiovascular Devices Market Outlook, By Therapeutic And Surgical Devices (2023-2034) ($MN)
  • Table 73 Asia Pacific Cardiovascular Devices Market Outlook, By Cardiac Assist Devices (2023-2034) ($MN)
  • Table 74 Asia Pacific Cardiovascular Devices Market Outlook, By Catheters (2023-2034) ($MN)
  • Table 75 Asia Pacific Cardiovascular Devices Market Outlook, By Cardiac Rhythm Management Devices (2023-2034) ($MN)
  • Table 76 Asia Pacific Cardiovascular Devices Market Outlook, By Grafts (2023-2034) ($MN)
  • Table 77 Asia Pacific Cardiovascular Devices Market Outlook, By Stents (2023-2034) ($MN)
  • Table 78 Asia Pacific Cardiovascular Devices Market Outlook, By Heart Valves (2023-2034) ($MN)
  • Table 79 Asia Pacific Cardiovascular Devices Market Outlook, By Application (2023-2034) ($MN)
  • Table 80 Asia Pacific Cardiovascular Devices Market Outlook, By Coronary Artery Disease (CAD) (2023-2034) ($MN)
  • Table 81 Asia Pacific Cardiovascular Devices Market Outlook, By Heart Failure (2023-2034) ($MN)
  • Table 82 Asia Pacific Cardiovascular Devices Market Outlook, By Cardiac Arrhythmia (2023-2034) ($MN)
  • Table 83 Asia Pacific Cardiovascular Devices Market Outlook, By Other Applications (2023-2034) ($MN)
  • Table 84 Asia Pacific Cardiovascular Devices Market Outlook, By End User (2023-2034) ($MN)
  • Table 85 Asia Pacific Cardiovascular Devices Market Outlook, By Specialty Clinics (2023-2034) ($MN)
  • Table 86 Asia Pacific Cardiovascular Devices Market Outlook, By Hospitals (2023-2034) ($MN)
  • Table 87 Asia Pacific Cardiovascular Devices Market Outlook, By Cardiac Centers (2023-2034) ($MN)
  • Table 88 Asia Pacific Cardiovascular Devices Market Outlook, By Centers Ambulatory Surgical (2023-2034) ($MN)
  • Table 89 South America Cardiovascular Devices Market Outlook, By Country (2023-2034) ($MN)
  • Table 90 South America Cardiovascular Devices Market Outlook, By Device Type (2023-2034) ($MN)
  • Table 91 South America Cardiovascular Devices Market Outlook, By Diagnostic And Monitoring Devices (2023-2034) ($MN)
  • Table 92 South America Cardiovascular Devices Market Outlook, By Remote Cardiac Monitoring (2023-2034) ($MN)
  • Table 93 South America Cardiovascular Devices Market Outlook, By Electrocardiogram (ECG) (2023-2034) ($MN)
  • Table 94 South America Cardiovascular Devices Market Outlook, By Therapeutic And Surgical Devices (2023-2034) ($MN)
  • Table 95 South America Cardiovascular Devices Market Outlook, By Cardiac Assist Devices (2023-2034) ($MN)
  • Table 96 South America Cardiovascular Devices Market Outlook, By Catheters (2023-2034) ($MN)
  • Table 97 South America Cardiovascular Devices Market Outlook, By Cardiac Rhythm Management Devices (2023-2034) ($MN)
  • Table 98 South America Cardiovascular Devices Market Outlook, By Grafts (2023-2034) ($MN)
  • Table 99 South America Cardiovascular Devices Market Outlook, By Stents (2023-2034) ($MN)
  • Table 100 South America Cardiovascular Devices Market Outlook, By Heart Valves (2023-2034) ($MN)
  • Table 101 South America Cardiovascular Devices Market Outlook, By Application (2023-2034) ($MN)
  • Table 102 South America Cardiovascular Devices Market Outlook, By Coronary Artery Disease (CAD) (2023-2034) ($MN)
  • Table 103 South America Cardiovascular Devices Market Outlook, By Heart Failure (2023-2034) ($MN)
  • Table 104 South America Cardiovascular Devices Market Outlook, By Cardiac Arrhythmia (2023-2034) ($MN)
  • Table 105 South America Cardiovascular Devices Market Outlook, By Other Applications (2023-2034) ($MN)
  • Table 106 South America Cardiovascular Devices Market Outlook, By End User (2023-2034) ($MN)
  • Table 107 South America Cardiovascular Devices Market Outlook, By Specialty Clinics (2023-2034) ($MN)
  • Table 108 South America Cardiovascular Devices Market Outlook, By Hospitals (2023-2034) ($MN)
  • Table 109 South America Cardiovascular Devices Market Outlook, By Cardiac Centers (2023-2034) ($MN)
  • Table 110 South America Cardiovascular Devices Market Outlook, By Centers Ambulatory Surgical (2023-2034) ($MN)
  • Table 111 Middle East & Africa Cardiovascular Devices Market Outlook, By Country (2023-2034) ($MN)
  • Table 112 Middle East & Africa Cardiovascular Devices Market Outlook, By Device Type (2023-2034) ($MN)
  • Table 113 Middle East & Africa Cardiovascular Devices Market Outlook, By Diagnostic And Monitoring Devices (2023-2034) ($MN)
  • Table 114 Middle East & Africa Cardiovascular Devices Market Outlook, By Remote Cardiac Monitoring (2023-2034) ($MN)
  • Table 115 Middle East & Africa Cardiovascular Devices Market Outlook, By Electrocardiogram (ECG) (2023-2034) ($MN)
  • Table 116 Middle East & Africa Cardiovascular Devices Market Outlook, By Therapeutic And Surgical Devices (2023-2034) ($MN)
  • Table 117 Middle East & Africa Cardiovascular Devices Market Outlook, By Cardiac Assist Devices (2023-2034) ($MN)
  • Table 118 Middle East & Africa Cardiovascular Devices Market Outlook, By Catheters (2023-2034) ($MN)
  • Table 119 Middle East & Africa Cardiovascular Devices Market Outlook, By Cardiac Rhythm Management Devices (2023-2034) ($MN)
  • Table 120 Middle East & Africa Cardiovascular Devices Market Outlook, By Grafts (2023-2034) ($MN)
  • Table 121 Middle East & Africa Cardiovascular Devices Market Outlook, By Stents (2023-2034) ($MN)
  • Table 122 Middle East & Africa Cardiovascular Devices Market Outlook, By Heart Valves (2023-2034) ($MN)
  • Table 123 Middle East & Africa Cardiovascular Devices Market Outlook, By Application (2023-2034) ($MN)
  • Table 124 Middle East & Africa Cardiovascular Devices Market Outlook, By Coronary Artery Disease (CAD) (2023-2034) ($MN)
  • Table 125 Middle East & Africa Cardiovascular Devices Market Outlook, By Heart Failure (2023-2034) ($MN)
  • Table 126 Middle East & Africa Cardiovascular Devices Market Outlook, By Cardiac Arrhythmia (2023-2034) ($MN)
  • Table 127 Middle East & Africa Cardiovascular Devices Market Outlook, By Other Applications (2023-2034) ($MN)
  • Table 128 Middle East & Africa Cardiovascular Devices Market Outlook, By End User (2023-2034) ($MN)
  • Table 129 Middle East & Africa Cardiovascular Devices Market Outlook, By Specialty Clinics (2023-2034) ($MN)
  • Table 130 Middle East & Africa Cardiovascular Devices Market Outlook, By Hospitals (2023-2034) ($MN)
  • Table 131 Middle East & Africa Cardiovascular Devices Market Outlook, By Cardiac Centers (2023-2034) ($MN)
  • Table 132 Middle East & Africa Cardiovascular Devices Market Outlook, By Centers Ambulatory Surgical (2023-2034) ($MN)